Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.
Yanlin Wang,Zhilei Wang,Huifang Sun,Chengyuan Mao,Jing Yang,Yutao Liu,Han Liu,Shoutao Zhang,Jin Zhang,Yuming Xu,Changhe Shi
DOI: https://doi.org/10.1016/j.scr.2018.08.011
IF: 1.587
2018-01-01
Stem Cell Research
Abstract:CHCHD2 mutation has been reported as a potential cause of a rare form of familial Parkinson's disease. Recently, a novel CHCHD2 mutation was identified in a family with Parkinson's disease. The dermal fibroblasts of the patient were obtained and successfully transformed into induced pluripotent stem cells(iPSCs), employing episomal plasmids expressing OCT3/4, SOX2, KLF4, LIN28, and L-MYC. Our model may offer a good platform for further research on the pathomechanism, drug testing, and gene therapy of this disease.